BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo S, Du L, Cui Y. Potential Therapeutic Applications and Developments of Exosomes in Parkinson’s Disease. Mol Pharmaceutics 2020;17:1447-57. [DOI: 10.1021/acs.molpharmaceut.0c00195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh A, Maharana SK, Shukla R, Kesharwani P. Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease. Process Biochemistry 2021;110:181-94. [DOI: 10.1016/j.procbio.2021.08.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ouerdane Y, Hassaballah MY, Nagah A, Ibrahim TM, Mohamed HAH, El-baz A, Attia MS. Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications. Pharmaceuticals 2022;15:76. [DOI: 10.3390/ph15010076] [Reference Citation Analysis]
3 Kučuk N, Primožič M, Knez Ž, Leitgeb M. Exosomes Engineering and Their Roles as Therapy Delivery Tools, Therapeutic Targets, and Biomarkers. Int J Mol Sci 2021;22:9543. [PMID: 34502452 DOI: 10.3390/ijms22179543] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mittal R, Bencie N, Langlie J, Mittal J, Eshraghi AA. Exosomes as drug delivery vehicles and biomarkers for neurological and auditory systems. J Cell Physiol 2021. [PMID: 34224589 DOI: 10.1002/jcp.30484] [Reference Citation Analysis]
5 Campese N, Beatino MF, Del Gamba C, Belli E, Giampietri L, Del Prete E, Galgani A, Vergallo A, Siciliano G, Ceravolo R, Hampel H, Baldacci F. Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer's and other neurodegenerative diseases. Expert Rev Neurother 2021;:1-19. [PMID: 34365867 DOI: 10.1080/14737175.2021.1965879] [Reference Citation Analysis]
6 Baskin J, Jeon JE, Lewis SJG. Nanoparticles for drug delivery in Parkinson's disease. J Neurol 2021;268:1981-94. [PMID: 33141248 DOI: 10.1007/s00415-020-10291-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Luo S, Sun X, Huang M, Ma Q, Du L, Cui Y. Enhanced Neuroprotective Effects of Epicatechin Gallate Encapsulated by Bovine Milk-Derived Exosomes against Parkinson's Disease through Antiapoptosis and Antimitophagy. J Agric Food Chem 2021;69:5134-43. [PMID: 33890462 DOI: 10.1021/acs.jafc.0c07658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Min W, Wu Y, Fang Y, Hong B, Dai D, Zhou Y, Liu J, Li Q. Bone marrow mesenchymal stem cells-derived exosomal microRNA-124-3p attenuates hypoxic-ischemic brain damage through depressing tumor necrosis factor receptor associated factor 6 in newborn rats. Bioengineered 2022;13:3194-206. [DOI: 10.1080/21655979.2021.2016094] [Reference Citation Analysis]
9 Siraj N, Bwambok DK, Brady PN, Taylor M, Baker GA, Bashiru M, Macchi S, Jalihal A, Denmark I, Le T, Elzey B, Pollard DA, Fakayode SO. Raman spectroscopy and multivariate regression analysis in biomedical research, medical diagnosis, and clinical analysis. Applied Spectroscopy Reviews 2021;56:615-72. [DOI: 10.1080/05704928.2021.1913744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Shaheen H, Singh S, Melnik R. A Neuron-Glial Model of Exosomal Release in the Onset and Progression of Alzheimer's Disease. Front Comput Neurosci 2021;15:653097. [PMID: 34616283 DOI: 10.3389/fncom.2021.653097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]